Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2024

Aug 19, 2024

32853_dirs_2024-08-19_11215af3-281b-43f1-bedb-43d6cd5a7b1a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2024-08-15

Reporting Person: Black Jeffrey G. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-15 Common Stock M 13157 Acquired 432993 Direct
2024-08-15 Common Stock F 4695 $1.55 Disposed 428298 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-15 Restricted Stock Units $ M 13157 Disposed Common Stock (13157) Direct

Footnotes

F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 15, 2023,
which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023.

F2: Each RSU represents the contingent right to receive one share of the Issuer's common stock.

F3: On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024.